title: An Updated Protocol for Evaluating Chest Pain and Managing Acute Coronary Syndromes.
abstract: Clinical pathways can optimize care both across and within institutions, but regular updates to these pathways based on new clinical trials, professional guidelines, and Food and Drug Administration approvals are essential. Herein we describe the most recent revisions to the New York-Presbyterian Hospital (Columbia University Medical Center and Weill Cornell Medical Center) clinical pathway for acute coronary syndromes and chest pain, which incorporates novel data regarding the timing and administration of P2Y12 inhibition (including the intravenous P2Y12 inhibitor cangrelor) and the appropriateness of prolonged (>1 year) dual antiplatelet therapy for the secondary prevention of ischemic events.
authors.affiliation: From the *Division of Cardiology, Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY; and †Division of Cardiology, Weill Cornell Medical Center/New York-Presbyterian Hospital, New York, NY.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Kelly
authors.forename: Ajay J
authors.initials: AJ
authors.lastname: Kirtane
authors.forename: Jennifer
authors.initials: J
authors.lastname: Stant
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.forename: Robert M
authors.initials: RM
authors.lastname: Minutello
authors.forename: S Chiu
authors.initials: SC
authors.lastname: Wong
authors.forename: Honeyleen
authors.initials: H
authors.lastname: Manuzon
authors.forename: Roxanne
authors.initials: R
authors.lastname: Gerow-Smith
authors.forename: Nancy
authors.initials: N
authors.lastname: Kelley
authors.forename: LeRoy E
authors.initials: LE
authors.lastname: Rabbani
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D002637:Chest Pain / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D019091:Critical Pathways; D019468:Disease Management; D006801:Humans